vs

Side-by-side financial comparison of APARTMENT INVESTMENT & MANAGEMENT CO (AIV) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.

Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.1M, roughly 1.8× APARTMENT INVESTMENT & MANAGEMENT CO). On growth, APARTMENT INVESTMENT & MANAGEMENT CO posted the faster year-over-year revenue change (16.7% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -79.5%).

Beach Point Capital Management is an American hedge fund management firm headquartered in Santa Monica, California.The firm focuses on credit related investments.

Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.

AIV vs IRD — Head-to-Head

Bigger by revenue
IRD
IRD
1.8× larger
IRD
$3.9M
$2.1M
AIV
Growing faster (revenue YoY)
AIV
AIV
+26.8% gap
AIV
16.7%
-10.2%
IRD
Faster 2-yr revenue CAGR
IRD
IRD
Annualised
IRD
50.3%
-79.5%
AIV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AIV
AIV
IRD
IRD
Revenue
$2.1M
$3.9M
Net Profit
$297.3M
Gross Margin
Operating Margin
Net Margin
14155.2%
Revenue YoY
16.7%
-10.2%
Net Profit YoY
2721.3%
53.0%
EPS (diluted)
$2.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIV
AIV
IRD
IRD
Q4 25
$2.1M
$3.9M
Q3 25
$35.1M
$3.1M
Q2 25
$52.8M
$2.9M
Q1 25
$52.4M
$4.4M
Q4 24
$1.8M
$4.3M
Q3 24
$35.3M
$3.9M
Q2 24
$51.1M
$1.1M
Q1 24
$50.2M
$1.7M
Net Profit
AIV
AIV
IRD
IRD
Q4 25
$297.3M
Q3 25
$283.1M
$-17.5M
Q2 25
$-19.3M
$-7.4M
Q1 25
$-13.9M
$-8.2M
Q4 24
Q3 24
$-21.9M
$-7.5M
Q2 24
$-60.5M
$-7.8M
Q1 24
$-10.2M
$-7.1M
Operating Margin
AIV
AIV
IRD
IRD
Q4 25
Q3 25
51.9%
-269.9%
Q2 25
56.0%
-309.0%
Q1 25
55.9%
-227.2%
Q4 24
Q3 24
50.0%
-207.1%
Q2 24
55.9%
-748.9%
Q1 24
57.8%
-450.5%
Net Margin
AIV
AIV
IRD
IRD
Q4 25
14155.2%
Q3 25
805.9%
-566.9%
Q2 25
-36.6%
-257.5%
Q1 25
-26.6%
-187.5%
Q4 24
Q3 24
-62.1%
-194.6%
Q2 24
-118.3%
-698.3%
Q1 24
-20.3%
-415.3%
EPS (diluted)
AIV
AIV
IRD
IRD
Q4 25
$2.07
Q3 25
$2.04
$-0.25
Q2 25
$-0.14
$-0.12
Q1 25
$-0.10
$-0.24
Q4 24
Q3 24
$-0.16
$-0.29
Q2 24
$-0.43
$-0.30
Q1 24
$-0.07
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIV
AIV
IRD
IRD
Cash + ST InvestmentsLiquidity on hand
$394.9M
$45.1M
Total DebtLower is stronger
$738.6M
Stockholders' EquityBook value
$361.9M
$15.3M
Total Assets
$1.7B
$50.2M
Debt / EquityLower = less leverage
2.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIV
AIV
IRD
IRD
Q4 25
$394.9M
$45.1M
Q3 25
$404.4M
$30.8M
Q2 25
$41.4M
$32.4M
Q1 25
$49.1M
$41.8M
Q4 24
$141.1M
$30.3M
Q3 24
$82.6M
$36.6M
Q2 24
$88.5M
$41.4M
Q1 24
$121.8M
$47.2M
Total Debt
AIV
AIV
IRD
IRD
Q4 25
$738.6M
Q3 25
$828.5M
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$829.7M
Q3 24
$1.3B
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
AIV
AIV
IRD
IRD
Q4 25
$361.9M
$15.3M
Q3 25
$62.0M
$6.0M
Q2 25
$91.7M
$17.5M
Q1 25
$110.5M
$5.1M
Q4 24
$123.0M
$6.7M
Q3 24
$229.8M
$34.3M
Q2 24
$253.5M
$40.6M
Q1 24
$335.8M
$46.1M
Total Assets
AIV
AIV
IRD
IRD
Q4 25
$1.7B
$50.2M
Q3 25
$2.1B
$36.1M
Q2 25
$1.9B
$38.7M
Q1 25
$1.9B
$48.2M
Q4 24
$2.0B
$36.9M
Q3 24
$2.1B
$40.4M
Q2 24
$2.1B
$44.8M
Q1 24
$2.1B
$51.8M
Debt / Equity
AIV
AIV
IRD
IRD
Q4 25
2.04×
Q3 25
13.37×
Q2 25
11.99×
Q1 25
9.80×
Q4 24
6.75×
Q3 24
5.44×
Q2 24
4.78×
Q1 24
3.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIV
AIV
IRD
IRD
Operating Cash FlowLast quarter
$8.1M
$-35.3M
Free Cash FlowOCF − Capex
$-91.5M
FCF MarginFCF / Revenue
-4358.6%
Capex IntensityCapex / Revenue
4744.0%
Cash ConversionOCF / Net Profit
0.03×
TTM Free Cash FlowTrailing 4 quarters
$-143.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIV
AIV
IRD
IRD
Q4 25
$8.1M
$-35.3M
Q3 25
$8.9M
$-6.2M
Q2 25
$9.7M
$-10.3M
Q1 25
$3.8M
$-9.0M
Q4 24
$47.0M
$-25.6M
Q3 24
$16.4M
$-5.1M
Q2 24
$8.0M
$-7.3M
Q1 24
$21.7M
$-5.7M
Free Cash Flow
AIV
AIV
IRD
IRD
Q4 25
$-91.5M
Q3 25
$-19.3M
Q2 25
$-16.8M
Q1 25
$-15.4M
Q4 24
$-113.0M
Q3 24
$-19.6M
Q2 24
$-28.9M
Q1 24
$-19.2M
FCF Margin
AIV
AIV
IRD
IRD
Q4 25
-4358.6%
Q3 25
-55.0%
Q2 25
-31.8%
Q1 25
-29.3%
Q4 24
-6280.2%
Q3 24
-55.4%
Q2 24
-56.5%
Q1 24
-38.3%
Capex Intensity
AIV
AIV
IRD
IRD
Q4 25
4744.0%
Q3 25
80.4%
Q2 25
50.1%
Q1 25
36.7%
Q4 24
8890.4%
Q3 24
101.9%
Q2 24
72.2%
Q1 24
81.5%
Cash Conversion
AIV
AIV
IRD
IRD
Q4 25
0.03×
Q3 25
0.03×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIV
AIV

Other Real Estate$2.0M97%
Other$66.0K3%

IRD
IRD

Segment breakdown not available.

Related Comparisons